Tab0 offers a suite of health-focused applications centered on its Personal Digital Twin platform. FastingWorks provides AI-powered nutrition analysis and intermittent fasting tracking with meal photo logging and Apple Health sync. HRVWorks analyzes heart rate variability data to deliver recovery scores and biological age calculations.
GlucoseWorks is in development to forecast meal-related glucose spikes without requiring a continuous glucose monitor. All apps share a privacy-first architecture with on-device processing and evidence-based recommendations derived from peer-reviewed research.
The global longevity and digital health market is expanding as consumers seek personalized health insights beyond generic population averages. Wearable device adoption and on-device AI capabilities are creating new opportunities for privacy-preserving health platforms that integrate multiple biometric data streams.
Tab0 targets this shift with its Personal Decision Intelligence vision, connecting health signals to actionable daily guidance. The company plans to expand beyond South Korea into North America and other global markets, positioning itself as a mainstream entry point for longevity-focused consumers.
Tab0 differentiates through its on-device AI approach that keeps health data local rather than requiring cloud uploads. The company integrates multiple biometric signals — HRV, sleep, nutrition, and glucose — into a unified Personal Digital Twin model that moves beyond simple data visualization to causal relationship analysis.
The founding team brings direct experience from leading Korean technology companies, and the company practices daily dogfooding of its own products. Peer-reviewed research underpins every feature, with transparent methodology that shows users why recommendations are made.
